Impact of immune checkpoint inhibitors on survival outcomes in advanced gastric cancer in Japan: A real-world analysis.

Toru KadonoSatoru IwasaToshiharu HiroseHidekazu HiranoNatsuko OkitaHirokazu ShojiAtsuo TakashimaKen Kato

Published in: Cancer medicine (2024)

The proportion of patients transitioning to third-line treatment and survival outcomes following progression on second-line treatment have improved since the approval of nivolumab. This drug might help to prolong overall survival in real-world practice.

Keyphrases

newly diagnosed
healthcare
primary care
squamous cell carcinoma
prognostic factors
radiation therapy
combination therapy
lymph node
patient reported
drug induced
data analysis
drug administration